| MKNK1 |
MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 |
PTPRA |
IPI00032333 |
7.14 |
Evidence |
|
| RPS6KA2 |
RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 |
PTPRA |
IPI00032333 |
7.14 |
Evidence |
|
| GRB10 |
IPI00012752 |
DUSP6 |
DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 |
7.14 |
Evidence |
|
| GRB10 |
IPI00012752 |
DUSP16 |
DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 |
7.14 |
Evidence |
|
| PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
GRB10 |
IPI00012752 |
7.14 |
Evidence |
|
| GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
GRB10 |
IPI00012752 |
7.14 |
Evidence |
|
| STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
MAP3K9 |
MAP3K9, MLK1, PRKE1: Mitogen-activated protein kinase kinase kinase 9 |
7.14 |
Evidence |
|
| WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
DNM1 |
DNM1, DNM: Dynamin-1 |
7.14 |
Evidence |
|
| STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
PTPRA |
IPI00032333 |
7.14 |
Evidence |
|
| STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
MARK2 |
IPI00555838 |
7.14 |
Evidence |
|
| STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
MAP3K9 |
MAP3K9, MLK1, PRKE1: Mitogen-activated protein kinase kinase kinase 9 |
7.14 |
Evidence |
|
| STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
LOC649805 |
Ig heavy chain V-II region COR |
7.14 |
Evidence |
|
| STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
EVL |
EVL, RNB6: Ena/VASP-like protein |
7.14 |
Evidence |
|
| STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
CRK |
CRK: Proto-oncogene C-crk |
7.14 |
Evidence |
|
| MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
PTPRA |
IPI00032333 |
7.14 |
Evidence |
|
| NOS2A |
NOS2A, NOS2: Nitric oxide synthase, inducible |
CAV2 |
CAV2: Caveolin-2 |
7.14 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
GRB10 |
IPI00012752 |
7.14 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
EVL |
EVL, RNB6: Ena/VASP-like protein |
7.14 |
Evidence |
|
| ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
IGHE |
IGHE: Ig epsilon chain C region |
7.14 |
Evidence |
|
| ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
FRS2 |
FRS2: Fibroblast growth factor receptor substrate 2 |
7.14 |
Evidence |
|
| ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
DNM2 |
DNM2, DYN2: Dynamin-2 |
7.14 |
Evidence |
|
| PTPN2 |
PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 |
FRS2 |
FRS2: Fibroblast growth factor receptor substrate 2 |
7.14 |
Evidence |
|
| PTPN2 |
PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 |
GRB10 |
IPI00012752 |
7.14 |
Evidence |
|
| GJA1 |
GJA1, GJAL: Gap junction alpha-1 protein |
MKNK1 |
MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 |
7.14 |
Evidence |
|
| GJA1 |
GJA1, GJAL: Gap junction alpha-1 protein |
RPS6KA2 |
RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 |
7.14 |
Evidence |
|